BNTC: Benitec Biopharma Inc Sotuvning sof marjinal rentabelligi

Benitec (BNTC) tovar belgisi

Benitec Biopharma Inc. jigar terapiyasi bo'yicha keng ko'lamli patent portfeliga ega bo'lib, bu uzoq muddatli daromadni ta'minlaydi. Ishlab chiqish samaradorligi tashqi sertifikatlangan hamkorlar tomonidan qo'llab-quvvatlanadi, bu esa ichki laboratoriyalarga tushadigan yukni kamaytiradi. Asosiy biznesning sof marjasi ushbu sinergiyaning natijasini aks ettiradi, bunda 0.00 eng so'nggi metrika ko'rsatkichini ifodalaydi. Kam uchraydigan ko'z patologiyalarini davolashga yo'naltirilgan dasturlarning diversifikatsiyalashgan portfeli biznesning umumiy moliyaviy risklarini minimallashtiradi.

Benitec Biopharma Inc. (BNTC) - Sotuvning sof marjinal rentabelligi 04.07.2022dan 19.11.2026gacha

Benitec (BNTC) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning dastlabki tahlili:Benitec Biopharma, BNTC
Benitec Biopharma Inc ishlab chiqargan mahsulot

Benitec Biopharma Inc. (BNTC) ulkan R&D investitsiyalari va FDA ning qat'iy nazorati tufayli yuqori operatsion xarajatlar bazasiga duch kelmoqda, bu esa hozirgi vaqtda daromadlilikni cheklamoqda. Ushbu ko'rsatkich barcha amortizatsiyalardan keyin tushumning sof foydaga aylangan qismini o'lchaydi; shuning uchun, sof foyda marjining keskin tebranishlari xarajatlar tuzilmasidagi g'ayritabiiy o'zgarishlar yoki ddRNAi patentlarining kapitalizatsiya samaradorligi haqida signal beradi.

Benitec Biopharma Inc. kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX